Navigation Links
DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
Date:12/15/2008

EL SEGUNDO, Calif., Dec. 15 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), today announced that it is working with the U.S. Department of Health and Human Services, Office of Inspector General ("OIG") to respond to a subpoena request for documents issued in connection with the civil investigation by the Department of Justice and the U.S. Attorney's Office for the Northern District of Georgia previously reported in the Company's Quarterly Report on 10-Q for the period ended September 30, 2008. The subpoena was sent from the OIG's office in Atlanta, Georgia and was received by the Company on December 12, 2008. The subpoena applies to the Company and its subsidiaries and covers a time period from January 1, 2003 to the present. In response to the subpoena, DaVita will produce a wide range of documents relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlicit, and Epogen. The Company intends to meet with representatives of the government to discuss the scope of the subpoena and the production of responsive documents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

To the Company's knowledge, no proceedings have been initiated against the Company at this time, although the Company cannot predict whether or when proceedings might be initiated. The Company intends to cooperate with the government's investigation.

"DaVita has been involved in several investigations over the last 9 years, including some covering issues that are repeated in this subpoena. We respect the government's need to ensure the appropriateness of healthcare provider practices, especially during times when pharmaceutical issues involve significant expense for Medicare. We look forward to meeting with government representatives on this new investigation and once again demonstrating the strength of our clinical outcomes and the integrity and comprehensiveness of DaVita's Compliance programs," said LeAnne Zumwalt, spokesperson for DaVita.

DaVita is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita.com Receives eHealthcare Leadership Award
2. DaVita.com Launches Physician Website
3. Tour DaVita Raises More Than $400K for Kidney Disease Awareness
4. DaVita Abstracts Accepted into American Society of Nephrology Meeting
5. Modern Healthcare Names DaVita One of the Best Places to Work
6. DaVita 3rd Quarter 2008 Results
7. Spokesman at the United Nations Joins DaVita
8. Tour DaVita Rides to Improve Kidney Disease Education
9. DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
10. DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards
11. DaVita Renal Dietitians Conduct First-Ever EYE on CKD Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... Therachat , a smart ... and providing demos of its smart journaling platform at the 125th American Psychological ... D.C. from August 3-6, 2017. , The APA Annual Convention is one of ...
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/25/2017)... TX (PRWEB) , ... July 25, 2017 , ... SignatureCare ... emergencies in the Austin, TX area 24 Hours a day. , The ... Austin, TX. , “We’ve been open four months now and things are running ...
(Date:7/24/2017)... ... 2017 , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been ... (SLMBNI), part of Saint Luke’s Health System . Dr. Upadhyaya has served in ... M.Sc., FAANS joins Stanley P. Fisher, M.D., who has served as medical ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health Services ... Health Services Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. ... will facilitate the development of a hub and spoke model for opioid treatment ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017 RK Logistics Group, ... of Pharmacy certification for its Fremont, CA ... solutions in the Tri-Valley and San Jose ... City of Fremont , with its Fremont Innovation ... to provide such a powerful resource to the hundreds of ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
(Date:7/11/2017)... 2017  The global market for liquid biopsy diagnostic ... million in 2016.  Although in early stages, the global ... particular as a result of the gradual shift towards ... introduction of a significant number of new liquid biopsy ... tumor biomarkers to guide treatment decisions. ...
Breaking Medicine Technology: